surmount-1 tirzepatide weight loss non-diabetic SURMOUNT-1: Drastically Reduces in Obese Patients Gastrointestinal tolerability and weight reduction

doi:10.3389/fendo.2024.1366940

Compound 59 was the most potent XO inhibitor in vitro, with an IC 50 value of 1.37 M, being 117.81 times more active than geniposide and 9.14 times more active than the drug allopurinol (Figure 18)

Bnh mch vnh: Tim truyn tnh mch 1200 3000 mg hoc truyn trc tip vo ng mch vnh tri 300 mg (50 mg 2 mL/pht)

1 2 Li H, Lee CH, Yoo KY, Choi JH, Park OK, Yan BC, Byun K, Lee B, Hwang IK, Won MH (December 2010)

All authors have no relationships or affiliations that may be perceived by readers to have influenced, or give the appearance of potentially influencing, what is written in the submitted paper